Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of GSK576428 (Fondaparinux Sodium) in Prevention of Venous Thromboembolism (VTE) After Abdominal Surgery

NCT00333021 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00333021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00333021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of GSK576428 (Fondaparinux Sodium) in Prevention of Venous Thromboembolism (VTE) After Abdominal Surgery
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2006
Completion date
February 28, 2007
Enrollment
127 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

venous thromboembolism